Literature DB >> 6245234

Nature of the Sendai virus receptor: glycoprotein versus ganglioside.

P S Wu, R W Ledeen, S Udem, Y A Isaacson.   

Abstract

Gangliosides were compared with glycoproteins as potential receptors for Sendai virus by incorporating measured amounts of the glycoconjugates into lecithin-cholesterol liposomes and measuring binding by a hemagglutination assay with sheep erythrocytes. HeLa cell gangliosides showed no binding activity toward the virus up to 15 micrograms of sialic acid per 5 mumol of lecithin-cholesterol, whereas HeLa cell glycoproteins incorporated into similar liposomes caused avid virus binding below 1 microgram of sialic acid. These sialoglycoproteins could be separated from the bulk of cell proteins by multiple chloroform-methanol extractions. Purified rat brain gangliosides at a level of 120 micrograms of sialic acid in liposomes did not bind virus, whereas chloroform-methanol-extracted rat brain proteins caused only marginal binding. Bovine brain gangliosides differed slightly from the rat brain mixture in showing weak binding properties. Our results thus indicate that glycoproteins, rather than gangliosides, are the natural receptors for Sendai virus and that tissues differ as to the quantity of such protein receptors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6245234      PMCID: PMC288547     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Characteristics of Sendai virus receptors in a model membrane.

Authors:  A M Haywood
Journal:  J Mol Biol       Date:  1974-03-15       Impact factor: 5.469

2.  External labeling of cell surface galactose and galactosamine in glycolipid and glycoprotein of human erythrocytes.

Authors:  C G Gahmberg; S I Hakomori
Journal:  J Biol Chem       Date:  1973-06-25       Impact factor: 5.157

3.  Interaction of Vibrio cholerae enterotoxin with cell membranes.

Authors:  P Cuatrecasas
Journal:  Biochemistry       Date:  1973-08-28       Impact factor: 3.162

4.  Deactivation of cholera toxin by a sialidase-resistant monosialosylganglioside.

Authors:  C A King; W E Van Heyningen
Journal:  J Infect Dis       Date:  1973-06       Impact factor: 5.226

5.  Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system.

Authors:  D M Neville
Journal:  J Biol Chem       Date:  1971-10-25       Impact factor: 5.157

6.  Differential reactivities of fetal and adult human erythrocytes to antisera directed against glycolipids of human erythrocytes.

Authors:  S I Hakomori
Journal:  Vox Sang       Date:  1969-06       Impact factor: 2.144

Review 7.  Early interaction between animal viruses and cells.

Authors:  K Lonberg-Holm; L Philipson
Journal:  Monogr Virol       Date:  1974

8.  Gangliosides of human myelin: sialosylgalactosylceramide (G7) as a major component.

Authors:  R W Ledeen; R K Yu; L F Eng
Journal:  J Neurochem       Date:  1973-10       Impact factor: 5.372

9.  Tissue receptor for cholera exotoxin: postulated structure from studies with GM1 ganglioside and related glycolipids.

Authors:  J Holmgren; I Lönnroth; L Svennerholm
Journal:  Infect Immun       Date:  1973-08       Impact factor: 3.441

10.  Gas--liquid chromatographic assay of lipid-bound sialic acids: measurement of gangliosides in brain of several species.

Authors:  R K Yu; R W Ledeen
Journal:  J Lipid Res       Date:  1970-11       Impact factor: 5.922

View more
  11 in total

1.  Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice.

Authors:  Hiroki Takeuchi; Keiko Imamura; Bin Ji; Kayoko Tsukita; Takako Enami; Keizo Takao; Tsuyoshi Miyakawa; Masato Hasegawa; Naruhiko Sahara; Nobuhisa Iwata; Makoto Inoue; Hideo Hara; Takeshi Tabira; Maiko Ono; John Q Trojanowski; Virginia M-Y Lee; Ryosuke Takahashi; Tetsuya Suhara; Makoto Higuchi; Haruhisa Inoue
Journal:  NPJ Vaccines       Date:  2020-03-25       Impact factor: 7.344

2.  Sendai virus-erythrocyte membrane interaction: quantitative and kinetic analysis of viral binding, dissociation, and fusion.

Authors:  D Hoekstra; K Klappe
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

3.  Effects of lectins on peripheral infections by herpes simplex virus of rat sensory neurons in culture.

Authors:  R J Ziegler; R S Pozos
Journal:  Infect Immun       Date:  1981-11       Impact factor: 3.441

4.  Treatment of human peripheral blood leukocytes with proteases does not affect Sendai virus-induced interferon production.

Authors:  K Tsukui; T Miura; E Tokunaga
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

5.  Identification of a human neuroectodermal tumor antigen (OFA-I-2) as ganglioside GD2.

Authors:  L D Cahan; R F Irie; R Singh; A Cassidenti; J C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

6.  Simple and rapid separation of ortho- and paramyxovirus glycoproteins.

Authors:  F X Bosch; A Mayer; R T Huang
Journal:  Med Microbiol Immunol       Date:  1980       Impact factor: 3.402

7.  Sendai virus utilizes specific sialyloligosaccharides as host cell receptor determinants.

Authors:  M A Markwell; J C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

Review 8.  Evolution of cell recognition by viruses: a source of biological novelty with medical implications.

Authors:  Eric Baranowski; Carmen M Ruiz-Jarabo; Nonia Pariente; Nuria Verdaguer; Esteban Domingo
Journal:  Adv Virus Res       Date:  2003       Impact factor: 9.937

9.  Specific gangliosides function as host cell receptors for Sendai virus.

Authors:  M A Markwell; L Svennerholm; J C Paulson
Journal:  Proc Natl Acad Sci U S A       Date:  1981-09       Impact factor: 11.205

10.  Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice.

Authors:  Hiroki Takeuchi; Keiko Imamura; Bin Ji; Kayoko Tsukita; Takako Enami; Keizo Takao; Tsuyoshi Miyakawa; Masato Hasegawa; Naruhiko Sahara; Nobuhisa Iwata; Makoto Inoue; Hideo Hara; Takeshi Tabira; Maiko Ono; John Q Trojanowski; Virginia M-Y Lee; Ryosuke Takahashi; Tetsuya Suhara; Makoto Higuchi; Haruhisa Inoue
Journal:  NPJ Vaccines       Date:  2020-03-24       Impact factor: 7.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.